Elite in Guillain-Barre Syndrome

Simon F. Rinaldi

Oxford, ENG, GB 
Elite in Guillain-Barre Syndrome
Oxford, ENG, GB 
OverviewLocationsClinical Research

Overview

Simon Rinaldi practices in Oxford, United Kingdom. Mr. Rinaldi is rated as an Elite expert by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Miller-Fisher Syndrome, and Chronic Polyradiculoneuritis.

His clinical research consists of co-authoring 68 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 30 articles and participated in 2 clinical trials in the study of Guillain-Barre Syndrome.

Gender
Male

Locations

Oxford, ENG OX39DU, United Kingdom
Other Locations
Radcliffe On Trent, ENG, United Kingdom
London, ENG, United Kingdom
Edinburgh, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Dundee, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label, Single Arm, Multi-centre, Phase II Study Investigating Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of Imlifidase in Patients With Guillain-Barré Syndrome, in Comparison With Matched Control Patients
An Open-label, Single Arm, Multi-centre, Phase II Study Investigating Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of Imlifidase in Patients With Guillain-Barré Syndrome, in Comparison With Matched Control Patients
Enrollment Status: Completed
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drug: Imlifidase
Study Phase: Phase 2
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
View 1 Less Clinical Trial

68 Total Publications

NKG2D receptor ligands are cell surface biomarkers for injured murine and human nociceptive sensory neurons.
NKG2D receptor ligands are cell surface biomarkers for injured murine and human nociceptive sensory neurons.
Journal: Journal of neuroinflammation
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rinaldi's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile